Ju DongYangMD
Gastroenterology • West Hollywood, CABiliary Tract Disease, Gastrointestinal Cancer, Hepatology & Liver Transplantation
Physician
Dr. Yang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8700 Beverly Blvd
West Hollywood, CA 90048Phone+1 310-423-6000Fax+1 310-423-2356
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Transplant Hepatology, 2018 - 2018- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 2014 - 2017
University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 2011 - 2014- Mayo Clinic College of MedicinePost-Doctoral Fellowship, 2009 - 2011
OtherClass of 2005, MD
Certifications & Licensure
CA State Medical License 2018 - 2026
MN State Medical License 2014 - 2019
AR State Medical License 2013 - 2015- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Clinical Trials
- Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study Start of enrollment: 2021 May 11
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Development and Validation of a Noninvasive Model for the Detection of High-Risk Varices in Patients With Unresectable Hepatocellular Carcinoma.Neehar D Parikh, Patricia Jones, Reena Salgia, Irun Bhan, Lauren T Grinspan
Clinical Gastroenterology and Hepatology. 2025-02-01 - Alcohol-related liver and extrahepatic malignancies: burden of disease and socioeconomic disparities in 2019.Pojsakorn Danpanichkul, Kanokphong Suparan, Nathorn Chaiyakunapruk, Thanida Auttapracha, Siwanart Kongarin
European Journal of Gastroenterology & Hepatology. 2025-02-01 - Editorial: Steatotic Liver Diseases Emerge as Rapidly Growing Drivers of Primary Liver Cancer in the United States-Author's Reply.Pojsakorn Danpanichkul, Donghee Kim, Chun Wei Pan, Amit G Singal, Ju Dong Yang
Alimentary Pharmacology & Therapeutics. 2025-01-23
Press Mentions
Acceptable Liver Transplant Outcomes Seen After ICI Therapy for Liver CancerAugust 19th, 2024- Acceptable Liver Transplant Outcomes Seen After ICI Therapy for Liver CancerAugust 19th, 2024
- Study: Transplant Possible After Immunotherapy for Advanced Liver Cancer PatientsAugust 8th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
